Patents by Inventor Piyush Koria

Piyush Koria has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170100506
    Abstract: A formulation and method of treating chronic wounds is presented. The formulation uses two different fusion peptides, one of which incorporates an elastase resistant peptide, to preserve the bioactivity of different functional peptides and growth factors in chronic wounds.
    Type: Application
    Filed: October 11, 2016
    Publication date: April 13, 2017
    Applicant: University of South Florida
    Inventors: Yuan Yuan, Piyush Koria
  • Patent number: 9616138
    Abstract: Disclosed herein are cargo carrying nanoparticles and pharmaceutical formulations thereof. The cargo carrying nanoparticles can self-assemble from cargo molecule subunits and/or targeting subunits. The cargo carrying molecules can be configured to induce macropinocytosis in a cell when a targeting moiety specifically binds a binding partner on the surface of a cell. The pharmaceutical formulations containing the cargo carrying nanoparticles disclosed herein can be administered to a patient for the treatment or prevention of cancer.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: April 11, 2017
    Assignee: University of South Florida
    Inventors: Raul Iglesias, Piyush Koria
  • Patent number: 8940868
    Abstract: The invention is based on the discovery of a potent growth factor delivery system by creating a fusion polypeptide that includes two portions: (i) keratinocyte growth factor protein, and (ii) an elastin-like peptide. This chimera can be administered directly to a wound site, accelerating recovery.
    Type: Grant
    Filed: October 6, 2010
    Date of Patent: January 27, 2015
    Assignee: The General Hospital Corporation
    Inventors: Piyush Koria, Martin L. Yarmush, Yaakov Nahmias
  • Publication number: 20110092422
    Abstract: The invention is based on the discovery of a potent growth factor delivery system by creating a fusion polypeptide that includes two portions: (i) keratinocyte growth factor protein, and (ii) an elastin-like peptide. This chimera can be administered directly to a wound site, accelerating recovery.
    Type: Application
    Filed: October 6, 2010
    Publication date: April 21, 2011
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Piyush Koria, Martin L. Yarmush, Yaakov Nahmias